Saratov JOURNAL of Medical and Scientific Research

Clinical significance of hyperglycemia in acute ischemic stroke

Year: 2018, volume 14 Issue: №2 Pages: 220-225
Heading: Neurology Article type: Original article
Authors: Izhbuldina G.l., Novikova L.B.
Organization: Bashkir State Medical University of the Russian Health Care, Ufa Clinical Hospital №18

Aim: to study the effect of hyperglycemia on the course and clinical outcome of ischemic stroke (IS) in the acute period. Material and Methods. A total of 862 patients with IS (370 men, 492 women), mean age was 66.1±10.8 years. The degree of neurological deficit (NIHSS scale) and functional disorders (Rankin scale), clinical outcome were assessed. When admitted to hospital, a study of the level of glycemia on an empty stomach was conducted. Results. In 186 (21.6%) patients type 2 diabetes Mellitus (DM) was diagnosed. In 27.8% of patients without DM and 76.3% of patients with DM hyperglycemia was detected. In patients without DM with hyperglycemia, higher than in patients with normoglycemia, the representation of women (by 9.9%), cardioembolic stroke (by 10.5%), severe neurological deficit (by 14.7%), gross impairment of vital activity (by 14.0%), a decrease in the frequency of noticeable positive dynamics (by 14.8%), an increase in mortality (by 11.5%). In patients with DM, hyperglycemia was associated with a higher assessment rate on the Rankin scale of 4-5 points (by 25.6%) and a decrease in the incidence of noticeable positive dynamics (by 27.7%). Conclusion. Development of IS is characterized by high representation of disorders of carbohydrate metabolism (21,6%). The severity of glucose metabolism disorders is interrelated with the severity and clinical outcome of the disease.

1. Bejot Y, Bailly H, Durier J, Giroud M. Epidemiology of stroke in Europe and trends for the 21st century. Presse Med 2016; 45 (12): e391-e398. DOI: 10.1016/j.lpm.2016.10.003
2. Gusev El, Skvorcova VI, Martynov MJu, Kamchatov PR. Cerebral stroke: problems and solutions. Bulletin of RSMU 2006; 51 (4): 28-32
3. Dedov II, Shestakova MV Cerebral vascular lesions in diabetes mellitus: solved and unresolved questions. Zhurnal nevrologii i psikhiatrii imeni S. S. Korsakova 2015; 8: 79-82
4. Bruno A, Leibeskind D, Нао Q, Raychev R. Diabetes mellitus, acute hyperglycemia, and ischemic stroke. Cur Treat Opt in Neurology 2010; 12: 492-503. DOI: 10.1007/ s11940-010-0093-6
5. Badiger Sh, Akkasaligar PT, Narone U. Hyperglycemia and Stroke. Int J Stroke Res 2013; 1:1-6
6. Clark ME, Payton JE, Pittiglio LI. Acute Ischemic Stroke and Hyperglycemia. Critical Care Nursing Quarterly 2014; 37: 182-187
7. Liang J, Liu W1, Sun J, Gu X, Ma Q, Tong W. Analysis of the risk factors for the short-term prognosis of acute ischemic stroke. IntJClin Exp Med 2015; 8 (11): 21915-24
8. M. Yao, J. Ni, L. Zhou, B. Peng, Yg Zhu, L. Cui, SMART investigators. Elevated Fasting Blood Glucose Is Predictive of Poor Outcome in Non-Diabetic Stroke Patients: A Sub-Group Analysis of SMART. PLoS One 2016; 11 (8): e0160674. DOI: 10.1371/journal.pone.0160674
9. Nasledov AD. SPSS 19: Professional statistical analysis of data. St. Petersburg: Piter, 2011; 400 p.
10. Dedov II, Shestakova MV, MajorovAJu, et al. Algorithms of specialized medical care for patients with diabetes. Diabetes Mellitus 2017; 20 (1S): 1-112. DOI: 10.14341/DM20171S8
11. American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care 2017; 40 (1): S11-S24.
12. Bilotta F, Rosa G. Glycemia management in critical care patients. World journal of diabetes 2012; 3 (7): 130-134. DOI: 10.4239/wjd.v3.i7.130
13. Suntsov Yl, Bolotskaya LL, Maslova OV, Kazakov IV Epidemiology of diabetes mellitus and prognosis of its prevalence in the Russian Federation. Diabetes mellitus 2011; 14(1): 15-19
14. Trunova ES, Fonakin AV, Geraskina LA, Samokhvalova EV Heart condition and the acute period of ischemic stroke. Clinical pharmacology and therapy 2007; (5): 55-58
15. Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ 2016; 355: i5953. DOI: 10.1136/bmj.i5953.

2018_2_220-225.pdf283.87 KB

No votes yet